The future of pleiotropic therapy in heart failure. Lessons from the benefits of exercise training on endothelial function
Sign Up to like & getrecommendations! Published in 2017 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.735
Abstract: A novel generation of drugs is introduced in the treatment of heart failure (HF). These drugs, including phosphodiesterase‐5 inhibitors, guanylate cyclase stimulators and activators, share the feature that their action is either endothelial‐mediated or substitutes… read more here.
Keywords: heart; heart failure; future pleiotropic; therapy ... See more keywords